Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Part of paid clinical trials in Naples, Florida.
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Study ID
- NCT05839730
- Status
- Recruiting
Conditions
- Concentric Hypertrophy
- Heart Failure With Preserved Ejection Fraction
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Pacemaker PLR + TRT ON — DEVICERAMware modified implantable pulse generator (IPG) with personalized lower rate (PLR) and tachycardia remodeling therapy (TRT) ON
- Pacemaker non-pacing mode or an exertional rate-adaptive pacing mode with no planned pacing at rest. — DEVICERAMware modified implantable pulse generator (IPG)
Study Details
FIRE-HFpEF is a multi-center, prospective, randomized, single-blinded, clinical feasibility study. This study will enroll up to 105 subjects with heart failure with preserved ejection fraction in the United States. Data will be collected to evaluate whether pacing therapies can lead to improvements in exercise capacity and health status of subjects.
Key Dates
- Start date
- Sep 11, 2024
- Status verified
- Jan 2026
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 105 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: Pacemaker with multiple pacing therapies enabledDevice will be programmed for personalized lower rate pacing (PLR) and tachycardiac remodeling pacing (TRT).
- Active Comparator: Pacemaker with no pacing therapies enabledDevice will be programmed to a non-pacing mode or an exertional rate-adaptive pacing mode with no planned pacing at rest.
Primary Outcome Measure
characterize the effect of TRT + PLR on cardiac structure. LV mass, LVEDV, LVESV, and wall thickness which will be collected at baseline, 3-month, 6-month, 9-month, and 12-month visits. [ Time Frame: Through study completion, projected for three years until last subject last 12-month visit. ]
Central Contacts
- Scott A Sarazin763-526-2817
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NCH Heart Institute | Naples | Florida | 34102 | Dinesh Sharma, MD |
| Prairie Education and Research Cooperative-St. Elizabeth's | O'Fallon | Illinois | 62269 | Ziad Issa, MD |
| Prairie Education and Research Cooperative-St. John's | Springfield | Illinois | 62769 | Ziad Issa, MD |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | Seth Sheldon, MD |
| Duke University | Durham | North Carolina | 27708 | Daniel Friedman, MD |
| Oklahoma Heart Hospital | Oklahoma City | Oklahoma | 73120 | Charles Te, MD |
| Houston Methodist Research Institute | Houston | Texas | 77030 | Miguel Valderrabano, MD |
| The University of Vermont Medical Center | Burlington | Vermont | 05401 | Nicole Habel, MD |
Find similar trials in Naples, FL
By condition
By specialty
By research site
Related Studies
- Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection FractionPHASE3 · Recruiting · Uppsala University · Alexander City, Alabama
- SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research PlanEARLY_PHASE1 · Recruiting · The University of Texas Health Science Center at San Antonio · San Antonio, Texas
- Assessment of CCM in HF With Higher Ejection FractionRecruiting · Impulse Dynamics · Birmingham, Alabama
- Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection FractionRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina